Literature DB >> 17763581

Clinicopathological characteristics of advanced colorectal cancer 30 mm or smaller in diameter.

Hong Zhang1, Chun-Sheng Chen, Jin-Chun Cong, Lei Qiao, Taisuke Hasegawa, Shigeki Takashima.   

Abstract

OBJECTIVE: To investigate the clinicopathological characteristics of advanced colorectal cancer which was 30 mm or smaller in diameter.
METHODS: Retrospective analysis documented 80 patients with small advanced colorectal cancer from May 1985 to May 2002. According to the diameter of tumors, all patients were divided into three groups: Group A (10 mm or less), Group B (11-20 mm), Group C (21-30 mm). Considering the number of patients in Group A was smaller, we combined Group A with Group B as Group D. Then various clinicopathological characteristics were compared between Group C and Group D.
RESULTS: The most common site of small advanced colorectal cancer was sigmoid colon and rectum that accounted for 36.2% and 35.0% of all cases. The average diameter of total tumors was 23.3 mm. Type 2 was the most common macroscopic type (63.7%) and the moderate differentiation was seen in 77.5% of cases. Thirty-eight (47.5%) cases had lymph node metastasis. Three (3.8%) cases had liver metastasis and three (3.8%) cases had peritoneal metastasis. The frequency of lymph node metastasis was found significantly different between Group C and Group D (54.2% vs. 28.6%, P < 0.05) , as well as between the groups with different depth of invasion (P < 0.05). Curability A resection was performed in 69 (86.2%) cases.
CONCLUSIONS: Tumor size and depth of invasion are related to lymph node metastasis in small advanced colorectal cancer. However, the small size of tumor may not always be a reliable parameter for estimating the risk of lymph node metastasis. Small colorectal cancers also do not always mean the early stage. Surgeons should be aware of the features of small advanced colorectal cancers to select ideal management and perform perfect resection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763581

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  6 in total

1.  Morphology as a risk factor for the malignant potential of T2 colorectal cancer.

Authors:  Yuichi Mori; Shin-Ei Kudo; Shungo Endo; Chiyo Maeda; Shumpei Mukai; Yasuharu Maeda; Shinichi Kataoka; Kenichi Takeda; Katsuro Ichimasa; Hideyuki Miyachi; Naruhiko Sawada; Eiji Hidaka; Fumio Ishida
Journal:  Mol Clin Oncol       Date:  2016-07-07

2.  Role of tumor size in the pre-operative management of rectal cancer patients.

Authors:  Inti Zlobec; Parham Minoo; Eva Karamitopoulou; George Peros; Efstratios S Patsouris; Frank Lehmann; Alessandro Lugli
Journal:  BMC Gastroenterol       Date:  2010-06-15       Impact factor: 3.067

3.  A simple scoring system based on clinical features to predict locally advanced rectal cancers.

Authors:  Guoxiang Cai; Ye Xu; Xiaoli Zhu; Junjie Peng; Zuofeng Li; Changchun Xiao; Xiang Du; Ji Zhu; Peng Lian; Weiqi Sheng; Zuqing Guan; Sanjun Cai
Journal:  J Gastrointest Surg       Date:  2009-04-15       Impact factor: 3.452

4.  Preoperative assessment of lymph node metastasis in clinically node-negative rectal cancer patients based on a nomogram consisting of five clinical factors.

Authors:  Chi Zhou; Hua-Shan Liu; Xuan-Hui Liu; Xiao-Bin Zheng; Tuo Hu; Zhen-Xing Liang; Xiao-Wen He; Xiao-Sheng He; Jian-Cong Hu; Xiao-Jian Wu; Xian-Rui Wu; Ping Lan
Journal:  Ann Transl Med       Date:  2019-10

5.  Development of a Novel Prognostic Model for Predicting Lymph Node Metastasis in Early Colorectal Cancer: Analysis Based on the Surveillance, Epidemiology, and End Results Database.

Authors:  Ji Hyun Ahn; Min Seob Kwak; Hun Hee Lee; Jae Myung Cha; Hyun Phil Shin; Jung Won Jeon; Jin Young Yoon
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

6.  Retrospective analysis of LNM risk factors and the effect of chemotherapy in early colorectal cancer: A Chinese multicenter study.

Authors:  Chunyan Zeng; Dandan Xiong; Fei Cheng; Qingtian Luo; Qiang Wang; Jun Huang; Guilian Lan; Huan Zhong; Youxiang Chen
Journal:  BMC Cancer       Date:  2020-11-05       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.